Growing epidemic of coronary heart disease in low-and middle-income countries

TA Gaziano, A Bitton, S Anand… - Current problems in …, 2010 - Elsevier
Coronary heart disease (CHD) is the single largest cause of death in the developed
countries and is one of the leading causes of disease burden in developing countries. In …

Acute coronary syndromes: diagnosis and management, part I

A Kumar, CP Cannon - Mayo Clinic Proceedings, 2009 - Elsevier
The term acute coronary syndrome (ACS) refers to any group of clinical symptoms
compatible with acute myocardial ischemia and includes unstable angina (UA), non—ST …

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation …

Authors/Task Force Members… - European heart …, 2008 - academic.oup.com
Document Reviewers: Sigmund Silber (CPG Review Coordinator)(Germany), Frank V.
Aguirre (USA), Nawwar Al-Attar (France), Eduardo Alegria (Spain), Felicita Andreotti (Italy) …

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

MA Pfeffer, JJV McMurray, EJ Velazquez… - … England Journal of …, 2003 - Mass Medical Soc
Background Angiotensin-converting–enzyme (ACE) inhibitors such as captopril reduce
mortality and cardiovascular morbidity among patients with myocardial infarction …

Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial

COMMIT (ClOpidogrel and Metoprolol in Myocardial … - The Lancet, 2005 - thelancet.com
Background Despite improvements in the emergency treatment of myocardial infarction (MI),
early mortality and morbidity remain high. The antiplatelet agent clopidogrel adds to the …

A clinical trial of the angiotensin-converting–enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction

L Køber, C Torp-Pedersen, JE Carlsen… - … England Journal of …, 1995 - Mass Medical Soc
Background Treatment with angiotensin-converting–enzyme (ACE) inhibitors reduces
mortality among survivors of acute myocardial infarction, but whether to use ACE inhibitors …

Management of acute myocardial infarction in patients presenting with ST-segment elevation

F Van de Werf, D Ardissino, A Betriu… - European heart …, 2003 - academic.oup.com
The management of acute myocardial infarction continues to undergo major changes. Good
practice should be based on sound evidence derived from well-conducted clinical trials …

Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial

COMMIT (ClOpidogrel and Metoprolol in Myocardial … - The Lancet, 2005 - thelancet.com
Background Despite previous randomised trials of early β-blocker therapy in the emergency
treatment of myocardial infarction (MI), uncertainty has persisted about the value of adding it …

Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information …

MSJ Sutton, MA Pfeffer, L Moye, T Plappert… - Circulation, 1997 - Am Heart Assoc
Background We quantified cardiovascular death and/or left ventricular (LV) dilatation in
patients from the SAVE trial to determine whether dilatation continued beyond 1 year …

Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease: The Task Force on ACE-inhibitors of the European Society of …

J Lopez-Sendon, K Swedberg, J McMurray… - European heart …, 2004 - academic.oup.com
The renin-angiotensin system plays a major role in cardiovascular disease and during the
past decade extensive research investigated the possible clinical benefit of the use of …